Corvus Pharmaceuticals, Inc. (CRVS) Earnings
|
Expand Research on CRVS
| Next EPS Date | 8/11/26 | EPS Growth Rate | -50.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +3.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +1.3% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$0.15 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/7/26 | Q126 | -$0.15 | -$0.15 | $0.00 | N/A | N/A | N/A |  | | Details | |
| 3/12/26 | Q425 | -$0.15 | -$0.13 | -$0.02 | N/A | $775K | N/A | | | Details | |
| 3/6/26 |
Q425 | N/A | -$0.13 | N/A | N/A | $775K | N/A | N/A | N/A | ||
| 3/5/26 |
Q425 | N/A | -$0.13 | N/A | N/A | $775K | N/A | N/A | N/A | ||
| 11/4/25 | Q325 | -$0.12 | -$0.13 | +$0.01 | N/A | N/A | N/A | | | Details | |
| 8/7/25 | Q225 | -$0.10 | -$0.13 | +$0.03 | N/A | N/A | N/A | | | Details | |
| 5/8/25 | Q125 | -$0.13 | -$0.12 | -$0.01 | N/A | N/A | N/A | | | Details |
